Skip to Content
Morningstar

Teva Pharmaceutical Industries Ltd ADR TEVA

Morningstar Rating
Unlock
Stock XNYS Rating as of
$16.93 +0.03 (0.18%)
View Full Chart
As of Delayed Price Pre-Open: $16.80 −0.10
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Teva: Lowering Uncertainty Due to Growing Innovative Portfolio, Strong Pipeline, and Debt Management

Keonhee Kim

After reviewing Teva Pharmaceutical's outlook, we've upgraded our Morningstar Uncertainty Rating to High from Very High. Our $14.50 fair value estimate and no-moat rating are unchanged. Our previous analysis considered unfavorable generic drug pricing trends, declining sales of off-patent branded drugs, and a significant level of debt, and we had difficulty seeing how the firm could quickly offset these challenges. However, we have seen significant improvements in recent quarters, with many thanks to the new management team led by CEO Richard Francis, who joined the firm about a year ago.

Read Full Report

Price vs Fair Value

View History
TEVA is trading within a range we consider fairly valued.
Price
$16.93
Fair Value
$12.50
Uncertainty
High
1-Star Price
$99.22
5-Star Price
$4.60
Economic Moat
Sxnfr
Capital Allocation
Rwcdwwdk

Bulls Say, Bears Say

Bulls

New products including Ajovy, Austedo (daily and extended release), and Uzedy will fuel Teva’s top and bottom lines as their adoption increases.

Bears

The majority of Teva's business lies in generic and off-patent branded drugs, which face price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply chain exert force.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TEVA is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$16.90
Day Range
$16.64–17.08
52-Week Range
$7.12–17.13
Bid/Ask
$16.77 / $16.80
Market Cap
$19.18 Bil
Volume/Avg
21,499 / 9.9 Mil

Key Statistics

Price/Earnings (Normalized)
6.40
Price/Sales
1.18
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Value
Total Number of Employees
37,851
Website
https://www.tevapharm.com

Competitors

Valuation

View More
Metric
TEVA
VTRS
RDY
Price/Earnings (Normalized)
 6.403.7518.98
Price/Book Value
 2.630.633.47
Price/Sales
 1.180.833.49
Price/Cash Flow
 11.893.8715.37
Price/Earnings
TEVA
VTRS
RDY

Financial Strength

Metric
TEVA
VTRS
RDY
Quick Ratio
 0.540.671.80
Current Ratio
 1.021.672.55
Interest Coverage
 0.391.3546.52
Quick Ratio
TEVA
VTRS
RDY

Profitability

Metric
TEVA
VTRS
RDY
Return on Assets (Normalized)
 6.03%7.07%15.57%
Return on Equity (Normalized)
 35.36%16.57%21.70%
Return on Invested Capital (Normalized)
 12.54%9.85%20.10%
Return on Assets
TEVA
VTRS
RDY
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRNgsmkfqrlfBvhvhv$78.4 Bil
ZTS
Zoetis Inc Class AXbqtyyvwmsLnp$77.9 Bil
HLN
Haleon PLC ADRNrkrkmghPtsqx$37.6 Bil
VTRS
Viatris IncSsmzhlcdCnrw$12.5 Bil
RDY
Dr Reddy's Laboratories Ltd ADRXlyddghqlBpvw$12.0 Bil
CTLT
Catalent IncLptsdmnbGhhkcv$9.7 Bil
PRGO
Perrigo Co PLCNdtmgdfdXbnhw$3.8 Bil
CURLF
Curaleaf Holdings IncSwtdxdbdsWmpmm$3.4 Bil
PBH
Prestige Consumer Healthcare IncYdfqbkzcVhdhfds$3.2 Bil

Sponsor Center